MedTrace Logo

Prospective, Multicenter Study of the Second Generation Antimicrobial Graft in the Abdominal Position

NCT00824109 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2010-12-03

No results posted yet for this study

Summary

The purpose of this prospective trial is to demonstrate the safety and performance of the Second Generation Anti-Microbial vascular graft in the treatment of aneurysmal and occlusive diseases of the abdominal aorta.

Conditions

  • Aneurysmal Disease of the Abdominal Aorta
  • Occlusive Disease of the Abdominal Aorta

Interventions

DEVICE

Second Generation Anti-Microbial bifurcated vascular graft (InterGard)

treatment of patients with aorto-iliac occlusion,stenosis, or aneurysm

Sponsors & Collaborators

  • Datascope Corp.

    lead INDUSTRY

Principal Investigators

  • Jean-Baptiste Ricco, MD · Vascular Surgery Dept, CHU La Miletrie

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • France

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00824109 on ClinicalTrials.gov